Shopping Cart 0
Cart Subtotal

Med BioGene Inc (MBI) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies


Med BioGene Inc (MBI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Med BioGene Inc (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. The company's lead test under development, GeneFx Lung formerly LungExpress Dx, is a proprietary gene expression based test. Its GeneFx Lung test is used to identify patients with early-stage non-small-cell lung cancer (NSCLC) and determine whether they are at higher or lower risk of mortality following the surgical removal of their tumor. The GeneFx Lung test is also expected to provide informed and personalized treatment decisions that assist in selecting the patients for adjuvant chemotherapy. Med BioGene is headquartered in Vancouver, British Columbia, Canada.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table Of Content


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Med BioGene Inc-Key Facts 5

Med BioGene Inc-Key Employees 6

Med BioGene Inc-Major Products and Services 7

Med BioGene Inc-History 8

Med BioGene Inc-Locations And Subsidiaries 10

Head Office 10

Other Locations & Subsidiaries 10

Section 2-Company Analysis 11

Company Overview 11

Med BioGene Inc-Business Description 12

Med BioGene Inc-SWOT Analysis 13

SWOT Analysis-Overview 13

Med BioGene Inc-Strengths 13

Med BioGene Inc-Weaknesses 14

Med BioGene Inc-Opportunities 15

Med BioGene Inc-Threats 16

Med BioGene Inc-Key Competitors 17

Section 3-Company Financial Ratios 18

Financial Ratios-Capital Market Ratios 18

Financial Ratios-Annual Ratios 19

Performance Chart 21

Financial Performance 21

Financial Ratios-Interim Ratios 22

Financial Ratios-Ratio Charts 23

Section 4-Company's Lifesciences Financial Deals and Alliances 24

Med BioGene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 24

Med BioGene Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 25

Med BioGene Inc, Recent Deals Summary 26

Section 5-Appendix 27

Methodology 27

Ratio Definitions 27

About GlobalData 31

Contact Us 31

Disclaimer 31

List Of Figure

List of Figures

Med BioGene Inc, Performance Chart (2013-2017) 21

Med BioGene Inc, Ratio Charts 23

Med BioGene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 24

Med BioGene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 25

List Of Table

List of Tables

Med BioGene Inc, Key Facts 5

Med BioGene Inc, Key Employees 6

Med BioGene Inc, Major Products and Services 7

Med BioGene Inc, History 8

Med BioGene Inc, Subsidiaries 10

Med BioGene Inc, Key Competitors 17

Med BioGene Inc, Ratios based on current share price 18

Med BioGene Inc, Annual Ratios 19

Med BioGene Inc, Annual Ratios (Cont...1) 20

Med BioGene Inc, Interim Ratios 22

Med BioGene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 24

Med BioGene Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 25

Med BioGene Inc, Recent Deals Summary 26

Currency Codes 27

Capital Market Ratios 27

Equity Ratios 28

Profitability Ratios 28

Cost Ratios 29

Liquidity Ratios 29

Leverage Ratios 30

Efficiency Ratios 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Med BioGene Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Oncolytics Biotech Inc

GeneNews Ltd

Celerus Diagnostics Inc